Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head & Neck Surgery

NCT03559920 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03559920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head & Neck Surgery
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2018
Completion date
March 31, 2019
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients who needs sedation after head & neck surgery